X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pharmacotherapy (233) 233
pharmacy (145) 145
humans (116) 116
pharmacology & pharmacy (103) 103
medicine & public health (95) 95
drug therapy (75) 75
pharmacology/toxicology (64) 64
index medicus (63) 63
internal medicine (62) 62
care and treatment (57) 57
dosage and administration (57) 57
toxicology (46) 46
research (40) 40
usage (38) 38
clinical trials (33) 33
adis drug evaluations (31) 31
pharmacokinetics (31) 31
drug dosages (29) 29
clinical trials as topic (28) 28
adis-clinical-q-and-a (25) 25
health aspects (25) 25
treatment outcome (24) 24
therapeutic use (23) 23
animals (22) 22
double-blind (22) 22
randomized controlled trials as topic (22) 22
quality of life (18) 18
biomedicine (17) 17
cancer research (17) 17
efficacy (17) 17
management (17) 17
molecular medicine (17) 17
pharmacodynamics (17) 17
adults (16) 16
analysis (16) 16
cost-benefit analysis (16) 16
diagnosis (16) 16
health economics (16) 16
immunology (16) 16
neurology (16) 16
oncology (16) 16
patients (16) 16
antibodies (15) 15
studies (15) 15
drugs (14) 14
health administration (14) 14
pharmacoeconomics and health outcomes (14) 14
psychiatry (14) 14
quality of life research (14) 14
therapy (14) 14
tolerability (14) 14
adis drug profiles (13) 13
adult (13) 13
children (13) 13
mutation (13) 13
safety (13) 13
child (12) 12
drug therapy, combination (12) 12
neurosciences (12) 12
pediatrics (12) 12
psychopharmacology (12) 12
risk factors (12) 12
antineoplastic agents - therapeutic use (11) 11
chemotherapy (11) 11
pharmacoeconomics (11) 11
prevention (11) 11
clinical neurology (10) 10
cost-effectiveness (10) 10
dose-response relationship, drug (10) 10
drug administration schedule (10) 10
female (10) 10
health care sciences & services (10) 10
pain (10) 10
placebo-controlled trial (10) 10
quality-of-life (10) 10
patient outcomes (9) 9
practice guidelines as topic (9) 9
trial (9) 9
administration, oral (8) 8
adolescent (8) 8
antibodies, monoclonal - therapeutic use (8) 8
antineoplastic agents - adverse effects (8) 8
complications and side effects (8) 8
cost effectiveness (8) 8
drug combinations (8) 8
metabolism (8) 8
pulmonary hypertension (8) 8
adis drug q&a (7) 7
breast cancer (7) 7
cancer (7) 7
cancer therapies (7) 7
enzymes (7) 7
epilepsy (7) 7
male (7) 7
multiple sclerosis (7) 7
pharmacology (7) 7
adis-drug-evaluations (6) 6
antineoplastic agents - pharmacology (6) 6
asthma (6) 6
cost analysis (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Drug Investigation, ISSN 1173-2563, 10/2019, Volume 39, Issue 10, pp. 1019 - 1019
The article Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features, written by KA Lyseng-Williamson, was originally... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology
Journal Article
Clinical Drug Investigation, ISSN 1173-2563, 9/2019, Volume 39, Issue 9, pp. 915 - 916
The original version of this article unfortunately contained some mistakes. The corrected details are provided below: 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology
Journal Article
Clinical Drug Investigation, ISSN 1173-2563, 8/2019, Volume 39, Issue 8, pp. 805 - 819
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are well established as effective adjuncts to lifestyle modification in the treatment of type 2 diabetes... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Adis Disease Management
Journal Article
Drugs and Therapy Perspectives, ISSN 1172-0360, 12/2018, Volume 34, Issue 12, pp. 543 - 553
Journal Article
Drugs & therapy perspectives : for rational drug selection and use, ISSN 1172-0360, 2019, Volume 35, Issue 1, p. 49
[This corrects the article DOI: 10.1007/s40267-018-0532-0.]. 
Journal Article
Drugs & therapy perspectives : for rational drug selection and use, ISSN 1172-0360, 2019, Volume 35, Issue 1, p. 46
[This corrects the article DOI: 10.1007/s40267-018-0572-5.]. 
Journal Article
Drugs and Therapy Perspectives, ISSN 1172-0360, 10/2018, Volume 34, Issue 10, pp. 457 - 465
Oral cabozantinib tablets (Cabometyx ) are an important option for the treatment of advanced renal cell carcinoma (RCC). Cabozantinib is an anti-angiogenic... 
Journal Article
Drugs & therapy perspectives : for rational drug selection and use, ISSN 1172-0360, 2018, Volume 34, Issue 12, p. 595
[This corrects the article DOI: 10.1007/s40267-018-0560-9.]. 
Journal Article
Drugs & therapy perspectives : for rational drug selection and use, ISSN 1172-0360, 2018, Volume 34, Issue 8, p. 404
[This corrects the article DOI: 10.1007/s40267-017-0459-x.]. 
Journal Article
Drugs, ISSN 0012-6667, 06/2013, Volume 73, Issue 9, pp. 949 - 949
Loteprednol etabonate ophthalmic gel 0.5 % (Lotemax-) is approved in the USA for the treatment of post-operative inflammation and pain in patients who have... 
Cataracts
Journal Article
Drugs and Therapy Perspectives, ISSN 1172-0360, 04/2018, Volume 34, Issue 4, pp. 194 - 195
Journal Article
Drugs & therapy perspectives : for rational drug selection and use, ISSN 1172-0360, 2018, Volume 34, Issue 12, p. 543
The EU indication for anakinra has been extended to include Still's disease, a serious rare inflammatory disorder of unknown aetiology that comprises... 
Journal Article
Drugs and Therapy Perspectives, ISSN 1172-0360, 08/2017, Volume 33, Issue 8, pp. 368 - 374
Journal Article
Drugs & Aging, ISSN 1170-229X, 11/2012, Volume 29, Issue 11, p. 911
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.